Low-intensity exercise training delays heart failure and improves survival in female hypertensive heart failure rats.
Exercise training improves functional capacity and quality of life in patients with heart failure. However, the long-term effects of exercise on mortality associated with hypertensive heart disease have not been well defined. In the present study, we investigated the effect of low-intensity exercise training on disease progression and survival in female spontaneously hypertensive heart failure rats. Animals with severe hypertension (16 months old) were treadmill trained (14.5 m/min, 45 min/d, 3 d/wk) until they developed terminal heart failure or were euthanized because of age-related complications. Exercise delayed mortality resulting from heart failure (P<0.001) and all causes (P<0.05) and transiently attenuated the systolic hypertension and contractile dysfunction observed in the sedentary animals but had no effect on cardiac morphology or contractile function in end-stage heart failure. Training had no effect on terminal myocardial protein expression of antioxidant enzymes, calcium handling proteins, or myosin heavy chain isoforms but was associated with higher cytochrome oxidase activity in cardiac mitochondria (P<0.05) and a greater mitochondrial content of cardiolipin, a phospholipid that is essential for optimal mitochondrial energy metabolism. In conclusion, low-intensity exercise training significantly delays the onset of heart failure and improves survival in female hypertensive heart failure rats without eliciting sustained improvements in blood pressure, cardiac function, or expression of several myocardial proteins associated with the cardiovascular benefits of exercise. The effects of exercise on cytochrome oxidase and cardiolipin provide novel evidence that training may improve prognosis in hypertensive heart disease by preserving mitochondrial energy metabolism.
Chicco
Adam J
AJ
Department of Integrative Physiology, University of Colorado Cardiovascular Research Institute, University of Colorado, Boulder, USA. chicco@cahs.colostate.edu
McCune
Sylvia A
SA
Emter
Craig A
CA
Sparagna
Genevieve C
GC
Rees
Meredith L
ML
Bolden
David A
DA
Marshall
Kurt D
KD
Murphy
Robert C
RC
Moore
Russell L
RL
D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D001794:Blood Pressure; D002135:Calcium-Binding Proteins / Q000378:metabolism; D002308:Cardiolipins / Q000378:metabolism; D004452:Echocardiography; D005260:Female; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000401:mortality* / Q000628:therapy*; D006973:Hypertension / Q000401:mortality* / Q000628:therapy*; D053208:Kaplan-Meier Estimate; D009206:Myocardium / Q000378:metabolism; D010805:Physical Conditioning, Animal / Q000502:physiology*; D051381:Rats; D011918:Rats, Inbred SHR
D000975:Antioxidants; D002135:Calcium-Binding Proteins; D002308:Cardiolipins